Clopidogrel is an antiplatelet, indicated for reducing the risk of heart disease and stroke in those at high risk. It is also used together with acetylsalicylic acid (Aspirin) after a heart attack or following the placement of a coronary artery stent (dual antiplatelet therapy).
Unipharm’s generic Clopidogrel Hydrogen Sulfate Tablets have been manufactured and marketed in Israel since 2009.
